Filter
276
Filtered Results: 276
Text search:
anticuerpos
Featured
Recommendations
15
New Publications
55
Language
Document type
Guidelines
131
No document type
87
Manuals
20
Studies & Reports
17
Fact sheets
10
Strategic & Response Plan
8
Training Material
1
Resource Platforms
1
Infographics
1
Countries / Regions
Brazil
48
Argentina
30
Latin America and the Carribbean
26
Paraguay
24
Colombia
23
Bolivia
15
Mozambique
14
Venezuela
13
Ecuador
10
Peru
8
Angola
8
Chile
7
Spain
5
El Salvador
4
Guinea-Bissau
4
Global
2
Dominican Republic
2
Mexico
1
Africa
1
Germany
1
North America
1
Portugal
1
Nicaragua
1
Honduras
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Guidelines
101
COVID-19
100
Policies & Guidelines HIV & TB
29
Studies & Reports
12
Women & Child Health
9
Chagas
7
Policies
6
Drugs & Medical Equipment
5
Virology
4
Yellow Fever
4
Immunization
4
Information, Education and Communication (IEC)
3
Leishmaniasis
3
Communicable Diseases
2
Hepatitis
2
Bacteriology
2
Vaccine-preventable Diseases
2
Capacity Building
2
Statistics
2
Parasitology
2
HIV & STI
2
Dental & Eye Care
1
Under-5 nutrition
1
Disaster Preparedness
1
General Guidelines
1
Vector Control
1
Breast Cancer
1
Pediatrics
1
Clinical Guidelines
1
Demograhic Health Surveys DHS
1
Humanitarian Crisis
1
Other
1
General Guidelines
1
Women & Child Health
1
Maternal Health
1
Dengue
1
Malaria
1
Disease Prevention & Control
1
Toolboxes
Country specific documents
79
Clinical Guidelines
22
Diagnostics & Laboratory Guidance
10
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
5
Children/Adolescents Mental Disorders
5
Infection Control General
5
Surveillance & Contact tracing
5
Biontech/Pfizer Comirnaty
4
Laboratory & Diagnostics
4
Gynaecology / Obstetrics
3
Yellow Fever Prevention & Control
3
Paediatrics
3
Physical Distancing
3
Communication Material
3
Immunization Guidelines
3
Moderna
3
Inactivated COVID-19 Vaccines
3
Essential Medicines & Devices Lists
3
National Emergency Response Plans
3
TB/HIV Coinfection
3
Chikungunya Prevention & Control
3
Health Systems
2
Laboratory Guidance
2
Dengue
2
Public Health
2
Context & Facts
2
Context & Facts, Travel Advice
2
COVID-19
2
For Pregnant Women
2
For Health Worker
2
Workplace
2
Genomic sequencing
2
SARS-CoV-2 Variants
2
Vaccine Hesitancy & Myths
2
Vaxzevria (Astra Zeneca)
2
Colombia
2
Chile
2
Other Countries
2
Clinical Aspects & Diagnostics
2
Clinical Guidelines
2
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2
Zika
2
Yellow Fever Situation Report
2
Paediatrics
2
Drugs
1
Outbreak Prevention & Control
1
Treatment Guidelines
1
TB & Drug Abuse
1
HIV testing & services
1
Clinical Aspects, Treatment & Prevention
1
Yellow Fever
1
Prevention & Control
1
Children & Adolescents
1
Surveillance
1
Men who have sex with men (MSM)
1
Latin America
1
Cholera
1
General
1
Prevention & Preparedness
1
For General Public & Community
1
Human Rights
1
Information for the Public
1
Educational Settings
1
LGBTI*
1
HIV and COVID-19
1
COVID-19
1
Infection Control & Prevention (IPC)
1
Essential Medicines & Medical Devices
1
Hospital Readiness/Essential Health Services
1
Blood Supply
1
Mythbusters/Misinformation
1
Tips & Best Practice Examples
1
Non-pharmaceutical interventions (NPIs)
1
TB/COVID-19
1
Vector-based Vacines General
1
Johnson & Johnson
1
Covaxin
1
Research & Pipeline
1
Others
1
Primary Care
1
Community Health Workers CHW
1
Nurses
1
Latin America
1
Booster Doses
1
Planetary Health
1
Clean air
1
Argentina
1
Pharmacovigilance
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Studies & Reports
1
Detection & Diagnosis
1
Autism
1
Contact Tracing
1
Alzheimer's Disease & Dementia
1
Prevention of Disabilites
1
Research & Access
1
Latin America & the Carribean
1
Testing Guidelines
1
Zika Prevention & Control
1
Antiretroviral Treatment ART
1
HIV in Key Populations
1
Chikungunya
1
Case Definitions
1
Cyclones Idai & Kenneth
1
Hoja de información
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that the blood services should take to mit...
Internews’ Rooted In Trust (RiT) Project tracks COVID-19-related rumors circulating among social media users and vulnerable communities in Colombia, as well as other countries around the globe. The rumors are used to inform risk communication efforts by humanitarians and public health actors, and ...
Orientaciones provisionales
9 de agosto de 2021
El presente documento tiene por objeto describir un conjunto mínimo de actividades de vigilancia recomendadas a nivel nacional para detectar y supervisar la prevalencia relativa de las variantes del SRAS-CoV-2 y esbozar un conjunto de actividades pa...
Guidelines for the Vaccination Scheme against
COVID 19: Booster Dose Health Personnel
Guidelines for the Vaccination Plan against COVID-19 in children 5 to 11 years, 11 months, 29 days with COVID-19 Vaccine Coronovac / Sinovac
Vaccinator's Manual. Pfizer-BioNTech Comirnaty Vaccine
Vaccinator's Manual. CONVIDECIA Vaccine
Vaccinator's Manual. MODERNA Vaccine
Tips and guidelines for the care of pregnant women and newborns in the context of the pandemic. ( version 16 June 2021)
Vaccinator's Manual SINOPHARM Vaccine - 28 FEBRUARY 2021
COVID-19, recomendaciones para el manejo
farmacológico / COVID-19, recommendations for pharmacological management
El presente documento establece las recomendaciones para la protección y el fomento de la lactancia materna en el contexto de la pandemia por COVID-19, para los equipos de salud que cuidan a díadas madre-hijo que se encuentran en período de lactancia, tanto en la atención primaria de salud como ...
Guía de tratamiento farmacológico y manejo deescenarios clínicos de casos de COVID-19 – enero 2022 Guía de tratamiento farmacológico y manejo deLeer más
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab...
Vacunación Antigripal 2022 - Guía rapida
